OptiBiotix Health Plc (AIM:OPTI)
10.25
0.00 (0.00%)
Oct 10, 2025, 4:19 PM GMT+1
OptiBiotix Health Revenue
OptiBiotix Health had revenue of 557.00K GBP in the half year ending June 30, 2025, with 58.69% growth. This brings the company's revenue in the last twelve months to 1.15M, up 102.28% year-over-year. In the year 2024, OptiBiotix Health had annual revenue of 870.00K with 35.09% growth.
Revenue (ttm)
1.15M
Revenue Growth
+102.28%
P/S Ratio
9.20
Revenue / Employee
115.10K
Employees
10
Market Cap
10.59M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 870.00K | 226.00K | 35.09% |
Dec 31, 2023 | 644.00K | 187.00K | 40.92% |
Dec 31, 2022 | 457.00K | -1.76M | -79.35% |
Dec 31, 2021 | 2.21M | 689.75K | 45.28% |
Dec 31, 2020 | 1.52M | 835.66K | 121.54% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |